C-cell hyperplasia of the thyroid — VA Rating Criteria (38 CFR DC 7919)
The VA rates C-cell hyperplasia of the thyroid under 38 CFR 38 CFR § 4.119, Diagnostic Code 7919, from 0% to 0% based on the frequency and functional severity of symptoms. The maximum 0% rating requires If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not requi…. Related conditions in the Endocrine body system share this rating framework.
What are the VA rating criteria for C-cell hyperplasia of the thyroid?
If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.
“If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.”
How does the VA rate Endocrine conditions?
Common Questions About C-cell hyperplasia of the thyroid VA Ratings
What is the VA disability rating for C-cell hyperplasia of the thyroid?
The VA rates C-cell hyperplasia of the thyroid under Diagnostic Code 7919 at the following tiers: 0%. The minimum 0% rating requires: If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.. The maximum 0% rating requires: If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903..
What is Diagnostic Code 7919?
Diagnostic Code 7919 is the VA rating identifier for C-cell hyperplasia of the thyroid within 38 CFR 38 CFR § 4.119. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.
What is the highest rating for C-cell hyperplasia of the thyroid?
The maximum rating for C-cell hyperplasia of the thyroid is defined in 38 CFR Part 4 under DC 7919. See the rating tiers above for exact criteria.
What 38 CFR section governs C-cell hyperplasia of the thyroid ratings?
C-cell hyperplasia of the thyroid is rated under 38 CFR 38 CFR § 4.119, Diagnostic Code 7919. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.
Which conditions are commonly secondary to C-cell hyperplasia of the thyroid?
Secondary conditions caused or aggravated by C-cell hyperplasia of the thyroid may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.
What evidence do I need to establish service connection for C-cell hyperplasia of the thyroid?
Service connection for C-cell hyperplasia of the thyroid requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits